• Trevi Therapeutics, Inc. (NASDAQ:TRVI) Given Average Recommendation of "Buy" by Brokerages

    Source: Buzz FX / 27 Jan 2025 04:41:18   America/New_York


    Trevi Therapeutics, Inc. (NASDAQ:TRVI) Given Average Recommendation of "Buy" by Brokerages Written by MarketBeat January 27, 2025 Share Link copied to clipboard. Trevi Therapeutics, Inc. ( NASDAQ:TRVI - Get Free Report ) has earned a consen
    Read more...
Share on,